Dashboard
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
With a fall in Net Sales of -16.36%, the company declared Very Negative results in Jan 70
With ROCE of 1.8, it has a Very Expensive valuation with a 1.6 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 660 Cr (Micro Cap)
215.00
40
0.27%
0.29
0.82%
1.71
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Falls to 52-Week Low of Rs.451.6 Amidst Prolonged Downtrend
Chemfab Alkalis has reached a new 52-week low of Rs.451.6, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock's subdued performance over the past year, contrasting sharply with broader market trends.
Read More
Chemfab Alkalis Stock Falls to 52-Week Low of Rs.458 Amidst Prolonged Earnings Pressure
Chemfab Alkalis has reached a new 52-week low of Rs.458, marking a significant decline in its stock price amid a challenging financial backdrop and extended period of subdued earnings performance.
Read More
Chemfab Alkalis Falls to 52-Week Low of Rs.461.3 Amidst Prolonged Downtrend
Chemfab Alkalis touched a new 52-week low of Rs.461.3 today, marking a significant milestone in its ongoing price decline. This level reflects a substantial contraction from its 52-week high of Rs.1,174.55, underscoring the stock’s challenging performance over the past year.
Read More Announcements 
Reg(30)- Change In Name Of The Wholly Owned Subsidiary Of The Company
03-Dec-2025 | Source : BSEIntimation of change in name of the Wholly Owned Subsidiary - CHEMFAB ALKALIS KARAIKAL LIMITED to CHEMFAB KARAIIKAL LIMITED w.e.f. 3rd December 2025.
Announcement under Regulation 30 (LODR)-Acquisition
14-Nov-2025 | Source : BSEIncorporation of Wholly Owned Subsidiary
Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015
11-Nov-2025 | Source : BSESubmission of restated trading plan wrt clarity price action based execution.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.0%)
Dr Rao Holdings Pte Ltd (47.07%)
V M Srinivasan (1.81%)
21.61%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -16.36% vs -0.84% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -178.82% vs 127.75% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -1.20% vs -5.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -89.29% vs -57.60% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






